BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30574724)

  • 1. Legality of Embryonic Gene Editing in Australia.
    Taylor-Sands M; Gyngell C
    J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Should We Regulate Heritable Human Genome Editing in Australia?
    Nicol D; Rudge C; Paxton R; Niemeyer S
    J Law Med; 2022 Jun; 29(2):322-336. PubMed ID: 35819374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
    Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
    J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 and the Promise of a Better Future.
    Raposo VL
    Eur J Health Law; 2019 Oct; 26(4):308-329. PubMed ID: 31597119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Editing Clinical Trials Could Slip through Australian Regulatory Cracks.
    Nicol D; Eckstein L
    J Law Med; 2019 Dec; 27(2):274-283. PubMed ID: 32129035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
    Musunuru K
    JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heritable Genome Editing and the Downsides of a Global Moratorium.
    Macintosh KL
    CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.